Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Labcorp’s Quarterly Earnings Preview: What You Need to Know

Labcorp Holdings Inc. (LH), headquartered in Burlington, North Carolina, stands as a premier global life sciences company specializing in clinical laboratory services. It manages one of the largest worldwide networks of labs and patient service centers in routine clinical, oncology, genetics, and esoteric diagnostics. Labcorp partners with physicians, hospitals, biopharma firms, and patients to advance healthcare decisions and accelerate drug development. The company has a market capitalization of $21.03 billion. 

The company is expected to report its fourth-quarter results for fiscal 2025 soon. Ahead of the release, Wall Street analysts are optimistic about the company’s bottom-line trajectory. 

Fundamentals

See More
  • Market Capitalization, $K 20,875,048
  • Shares Outstanding, K 82,900
  • Annual Sales, $ 13,009 M
  • Annual Income, $ 746,000 K
  • EBIT $ 1,615 M
  • EBITDA $ 2,258 M
  • 60-Month Beta 1.00
  • Price/Sales 1.54
  • Price/Cash Flow 11.37
  • Price/Book 2.43

Options Overview Details

View History
  • Implied Volatility 26.58% (+0.94%)
  • Historical Volatility 17.01%
  • IV Percentile 86%
  • IV Rank 40.00%
  • IV High 41.59% on 04/10/25
  • IV Low 16.57% on 08/22/25
  • Expected Move (DTE 6) 11.50 (4.57%)
  • Put/Call Vol Ratio 0.95
  • Today's Volume 39
  • Volume Avg (30-Day) 152
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 4,702
  • Open Int (30-Day) 3,879
  • Expected Range 240.31 to 263.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 3.95
  • Number of Estimates 8
  • High Estimate 3.98
  • Low Estimate 3.86
  • Prior Year 3.45
  • Growth Rate Est. (year over year) +14.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
245.00 +2.78%
on 01/05/26
266.99 -5.69%
on 12/15/25
-6.25 (-2.42%)
since 12/09/25
3-Month
244.52 +2.98%
on 11/07/25
293.72 -14.27%
on 10/21/25
-25.97 (-9.35%)
since 10/09/25
52-Week
209.38 +20.27%
on 04/21/25
293.72 -14.27%
on 10/21/25
+17.50 (+7.47%)
since 01/08/25

Most Recent Stories

More News
Labcorp’s Quarterly Earnings Preview: What You Need to Know

Here’s what you need to know about Labcorp Holdings prior to its Q4 earnings release.

XLV : 157.31 (-0.51%)
$SPX : 6,966.28 (+0.65%)
LH : 251.81 (-1.12%)
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results

LH : 251.81 (-1.12%)
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

TOLEDO, Ohio , Jan. 8, 2026 /PRNewswire/ -- NAMSA , a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition...

LH : 251.81 (-1.12%)
3 Low-Volatility Stocks with Questionable Fundamentals

3 Low-Volatility Stocks with Questionable Fundamentals

BV : 13.15 (+1.08%)
TRMK : 40.09 (-0.99%)
LH : 251.81 (-1.12%)
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. , Dec. 30, 2025 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate...

LH : 251.81 (-1.12%)
Is Charles River Laboratories Stock Underperforming the Dow?

Despite lagging the Dow Jones Industrial Average over the past year, Charles River Laboratories continues to attract cautious optimism from analysts regarding its longer-term outlook.

JPM : 329.19 (-0.18%)
$DOWI : 49,504.07 (+0.48%)
CRL : 220.91 (+2.51%)
LH : 251.81 (-1.12%)
How Is Labcorp Holdings' Stock Performance Compared to Other Healthcare Stocks?

Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic about the stock’s prospects.

XLV : 157.31 (-0.51%)
DGX : 174.44 (-1.86%)
LH : 251.81 (-1.12%)
3 Profitable Stocks That Fall Short

3 Profitable Stocks That Fall Short

FCFS : 164.91 (-0.22%)
LH : 251.81 (-1.12%)
WD : 65.00 (+4.23%)
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

OMCL : 50.74 (+0.30%)
MCK : 816.06 (+0.18%)
LH : 251.81 (-1.12%)
3 Reasons to Avoid LH and 1 Stock to Buy Instead

3 Reasons to Avoid LH and 1 Stock to Buy Instead

LH : 251.81 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C.

See More

Key Turning Points

3rd Resistance Point 260.12
2nd Resistance Point 258.42
1st Resistance Point 255.11
Last Price 251.81
1st Support Level 250.10
2nd Support Level 248.40
3rd Support Level 245.09

See More

52-Week High 293.72
Fibonacci 61.8% 261.50
Last Price 251.81
Fibonacci 50% 251.55
Fibonacci 38.2% 241.59
52-Week Low 209.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar